Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2005
03/24/2005WO2005007662A3 Biphosphine ruthenium complexes with chiral diamine ligande as catalysts
03/24/2005WO2004111193A3 Prodrugs of mitotic kinesin inhibitors
03/24/2005WO2004087050A3 Mitotic kinesin inhibitors
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005US20050065346 anticoagulants; thrombosis; factor x inhibitor
03/24/2005US20050065339 Amino-alkyl derivatives
03/24/2005US20050065211 Ester derivatives
03/24/2005US20050065204 Process for the preparation of enantiopure pyrrolidin-2-one derivatives
03/24/2005US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/24/2005US20050065142 Antidiabetic agents; therapy for insulin resistance
03/24/2005US20050065139 Antidiabetic agents; controlling carbohydrate metabolism
03/24/2005US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin
03/24/2005US20050065096 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005DE10341234A1 Novel N-acyl-hydroxyamino acid alkylamides with a ceramide-like structure are useful in compositions used for protection of skin or hair
03/24/2005CA2539454A1 Preventive for cerebral stroke recurrence
03/24/2005CA2539158A1 Crystalline forms of ['r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
03/24/2005CA2539049A1 Quinazoline derivatives
03/24/2005CA2539037A1 Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1193988C Preparation of 2-aryl-5-(trifluoride) pyrrole-3-nitrile and method of its intermediate thereof
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023838A1 Process for the manufacture of an enantiopure compound
03/17/2005WO2005023799A1 Fused bicyclic carboxamide derivatives and methods of their use
03/17/2005WO2005023766A1 Salt of atorvastatin with metformin
03/17/2005WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2
03/17/2005WO2005023764A1 Salt of atorvastatin with ranitidine
03/17/2005WO2005023763A1 Process for the preparation of pure levetiracetam
03/17/2005WO2005023762A1 Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
03/17/2005WO2005023260A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005US20050059829 Using cyano compound in presence of catalyst on support; cyclization; ink jet compound
03/17/2005US20050059824 Using carbon dioxide; salt formation, hydrolysis
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059659 Carotenoid analogs or derivatives for controlling C-reactive protein levels
03/17/2005US20050059652 Open chain prolyl urea-related modulators of androgen receptor function
03/17/2005US20050059635 Astaxanthin, beta-carotene, zeanthin, canthaxanthin
03/17/2005CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513807A1 Pharmaceutical combination
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/16/2005EP1513519A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
03/16/2005EP1203585B1 Anti-ischemic agent
03/16/2005EP1115758B1 Polymerization of olefins
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1594291A Process for preparing zofenopril
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193019C Method and reagents for N-alkylating ureides
03/16/2005CN1193014C Novol pyrrole sulphamide compound
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/15/2005US6867306 Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
03/15/2005US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm
03/15/2005US6867171 Liquids; easy to handle; paper chemicals, lubricants, dis-persants, detergents
03/15/2005US6867161 Titanium catalyst and organotitanium reacting reagent, production thereof, and reaction thereby
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021498A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005US20050054861 Process for converting alpha-angelica lactone to 5-methyl-N-alkyl-2-pyrrolidone using alkyl amines
03/10/2005US20050054859 Production of a N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines
03/10/2005US20050054857 Synthesis of pyrroles
03/10/2005US20050054856 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054630 Fused bicyclic carboxamide derivatives and methods of their use
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054559 Compounds for sustained release of orally delivered drugs
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2537123A1 New compounds
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511704A1 Polymerisation inhibitor
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005EP1018008B1 Method of identification of leads or active compounds
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 404